Search for homeopathic eye drops today and you will find plenty of pages describing them. What you will not find is the product itself, at least not from a US pharmacy shelf where it used to sit next to the saline and the allergy drops. The listings that survive tend to be older retailer pages, marketplace leftovers, and articles written before the category changed.
The reason is not a single recall or one company’s mistake. In December 2022, the FDA finalized a risk-based enforcement framework for homeopathic drug products, and it named ophthalmic products alongside injectables as one of the categories that pose a greater risk of harm because the route of administration bypasses some of the body’s natural defenses [1]. Everything applied directly to the eye fell under that heading at once.
We are The Relief Products, and we have spent more than three decades formulating homeopathic OTC medicines. We used to make eye products in drop form. We do not anymore. Our condition-specific eye care line is now Fast Dissolving Tablets, alongside one non-medicated lubricant drop. This piece explains what happened to the category, what the phrase “homeopathic eye drops” actually refers to when you still see it online, and what to look for instead.
Why Homeopathic Eye Drops Disappeared From Shelves
The December 2022 guidance (Docket FDA-2017-D-6580) did something narrower and more consequential than banning homeopathy. It set out how the agency would prioritize its enforcement attention across a category it does not review before sale, and it grouped the ophthalmic route of administration with injectables among the factors that raise enforcement priority. The reasoning in the document is structural rather than ingredient-based: both routes bypass some of the body’s natural defenses, so a contamination problem that would be minor elsewhere becomes serious.
That framing matters for understanding why the shelf emptied so uniformly. This was not one brand being pulled. It was a category-wide policy position that applied to every manufacturer making a homeopathic product intended for the eye, and the market responded accordingly.
The practical sequence went roughly like this. Guidance signaled where enforcement attention would land, major retailers and online marketplaces reassessed what they were willing to list, and manufacturers made their own calls about reformulating, discontinuing, or exiting the format. Very little of that was visible to shoppers. From the outside it looked like a product quietly stopped being restocked, which is exactly how most people discovered the change: they went to buy the thing they had bought before and it was not there.
The earlier hinge was 2019, when the FDA withdrew Compliance Policy Guide 400.400, the FDA-accepted framework the category had operated under for decades. We cover the full regulatory history and the pending legislation in our piece on the Homeopathic Drug Product Safety, Quality, and Transparency Act, so we will not re-litigate that ground here.
One point worth stating plainly, because it is often blurred in coverage: no homeopathic product has ever been FDA-approved, and homeopathic products marketed in the US have not been reviewed by the agency for safety and effectiveness [2]. That was true before 2019 and it is true now. What changed was not the approval status but the enforcement posture. If you are new to how these medicines are formulated in the first place, our overview of homeopathy covers the underlying principles.
The Specific Safety Concerns Behind the Eye Drop Ban
The case history in the 2022 guidance is specific. In 2019, four companies received warning letters over violations at a shared manufacturing facility producing eye drops of this kind. Inspectors documented non-sterile products contaminated with Bacillus species and pH levels high enough to risk glaucoma, corneal scarring, and vision loss [1]. Since 2020, the agency has issued more than 20 warning letters to homeopathic manufacturers over CGMP, sterility, and contamination violations [2].
Read carefully, those are manufacturing and sterility failures tied to the delivery format. They are not findings about the dilution principle homeopathy rests on. That distinction gets lost in most summaries, and it is the difference between “this product was made badly” and “this approach does not work.”
The strongest evidence for that reading is what has happened to conventional eye drops over the same period. The 2023 EzriCare contamination outbreak, traced to a drug-resistant Pseudomonas aeruginosa strain, caused 4 deaths, 14 cases of vision loss, and 80 infections nationally. In 2026, more than 3 million bottles of ordinary OTC eye drops were recalled across major store brands, cited for lack of assurance of sterility [3]. None of those products were homeopathic.
So the honest summary is a split rather than a verdict on one philosophy. The two kinds of eye drops sit in genuinely different regulatory positions, and shoppers tend to assume the difference is bigger in one direction than it actually is:
| Homeopathic eye drops | Conventional OTC eye drops | |
|---|---|---|
| Currently sold in the US | No, subject to category-wide enforcement | Yes, widely |
| FDA premarket review | None, and no product ever approved | None required for OTC |
| Must meet CGMP sterility standards | Yes | Yes |
| Recent contamination record | 2019 warning letters over a shared facility | Repeated recalls through 2023 to 2026 |
The row that surprises people is the second one. Conventional OTC eye drops do not go through FDA premarket review either [3]. Neither category is pre-cleared for safety and effectiveness before it reaches a shelf; the difference lies in where the agency has chosen to direct enforcement, and the ophthalmic route put homeopathic products at the front of that queue.
The common thread is the format. Anything sterile, packaged in a multi-dose bottle, and applied directly to the eye carries manufacturing risk that a tablet simply does not.
For completeness, the research picture on the formulations themselves is not empty. A randomized, single-masked, multicenter study of a European homeopathic ophthalmic formulation found it performed non-inferior to a saline comparator for mild-to-moderate dry eye disease, with better scores on dry eye sensation and burning [4]. That product is not sold in the US and is not one of ours. It is worth knowing that clinical data exists, and it does not change the fact that this category is currently unavailable here.
What “Homeopathic Eye Drops” Still on Sale Actually Are
If the FDA’s position is that these products should not be marketed, why can you still find the phrase attached to things you can add to a cart? Because enforcement is real but neither instantaneous nor complete. Major marketplaces have begun pulling homeopathic eyedrop listings following FDA warnings, but the removal has not reached every seller or every storefront, and older retailer pages, imports, and outdated catalogs can still surface the phrase [5]. Encountering the phrase is not evidence that a product cleared any review.
It is also worth separating two things the same phrase can describe. Some listings are genuine leftovers of the US category as it existed before the shift. Others are imported products from markets where homeopathic ophthalmic formulations are still sold under different rules, which is a real regulatory difference rather than a labeling quirk. Neither has been reviewed by the FDA, and from a shopper’s position on a product page the two are nearly impossible to tell apart.
The FDA’s consumer guidance on this is unusually direct. Its instruction is not to use ophthalmic products labeled as homeopathic, on the grounds that these products should not be marketed and are not FDA approved [6]. If you want a way to evaluate what you are looking at:
- Check whether it is both “homeopathic” and ophthalmic. That specific pairing, a homeopathic label on something meant to go in the eye, is the combination the FDA flagged. Either descriptor alone is a different situation.
- Look for how it was manufactured. Sterility for an eye product is a CGMP question. A seller who cannot tell you anything about manufacturing standards has told you something.
- Read the claim on the label. Legitimate OTC homeopathic labeling describes temporary relief from symptoms. Language about treating or curing a condition is a signal that the product is being marketed outside what the category permits.
- Check the seller as well as the brand. Third-party marketplace listings and unfamiliar international sellers are where legacy and mislabeled stock tends to live longest.
- When in doubt, skip it. The FDA’s own advice for this specific combination is not to use it [6].
What The Relief Products Uses Instead
We had to answer this question for ourselves before we could answer it for shoppers. Our eye care line was built on drops, and when the category shifted we reformulated rather than retired it.
Every condition-specific eye product we make is now a Fast Dissolving Tablet. Rather than being applied to the eye, it dissolves in the mouth, which sidesteps the ophthalmic-route risk that drove the enforcement decision in the first place. There is no sterile multi-dose bottle to contaminate, no dropper tip touching a lash line, and no preservative question, because nothing enters the eye at all.
That change also removed the part of the old format shoppers found fiddliest. Tilting your head back, aiming, blinking half the dose onto your cheek, and repeating because you are not sure it landed is a familiar routine for anyone who has used drops regularly. A tablet that dissolves under the tongue takes that guesswork out and works from the inside out, which is the philosophy the rest of our catalog already ran on.
Our current eye care line:
- Floaters Relief® Fast Dissolving Tablets™, which provides temporary relief from symptoms associated with eye floaters and spots.
- Pink Eye Relief™ Fast Dissolving Tablets™, covering pink eye symptoms such as redness, irritation, and watering.
- Allergy Eye Relief® Fast Dissolving Tablets™, aimed at itchy, watery, allergy-irritated eyes.
- Aging Eye Relief® Fast Dissolving Tablets™, which eases dryness and tired eyes that come with age.
- Complete Eye Relief™ Fast Dissolving Tablets™, a broader option for everyday eye discomfort.
- Stye Relief® Fast Dissolving Tablets™, for the discomfort a stye brings.
We do still make one product in drop form, and we want to be precise about what it is. Gentle Eyes Lubricant Eye Drops is a non-medicated lubricant drop for comfort and moisture. It is not a homeopathic remedy, and it does not carry the condition-specific symptom claims our former drop products did. If your eyes feel dry and you want a lubricating drop, that is what it is for. It is not a substitute for the tablets above.
The full range sits on our eye care collection page. The short version of our transition: the delivery format changed, the formulation philosophy did not.
When Eye Symptoms Need a Doctor Rather Than a Drop
No OTC product, ours included, is the right first move for every eye complaint. Some symptoms need an examination, and delaying one to try something from a shelf is the wrong trade.
See an eye doctor promptly if you notice:
- A sudden change in vision, including blurring, dark spots, or a curtain-like shadow.
- Significant eye pain rather than mild irritation or grittiness.
- New sensitivity to light.
- Any injury to the eye, or a chemical splash.
- Symptoms that last beyond a few days without improving.
- Discharge or drainage along with a fever, since that combination can signal an infection.
Eye care is one of the areas where the boundary between comfort and medical need is genuinely hard to read from home. Two people can describe the same redness and be in completely different situations, and the eye gives you very little margin to guess wrong. When you are unsure which side of that line you are on, the uncertainty is itself a reason to get looked at.
What we can say plainly is what our products are for: the everyday irritation, dryness, itching, and discomfort that come and go, where the goal is temporary relief from symptoms while your body does the rest. That is the lane homeopathic eye care occupied before the format changed, and it is the lane we still work in, now in a form that does not carry the risk the FDA acted on.
Frequently Asked Questions
Are homeopathic eye drops still legal to sell?
The FDA’s December 2022 guidance names ophthalmic homeopathic products, alongside injectables, as a category it prioritizes for enforcement because the route of administration bypasses some of the body’s natural defenses, and its consumer guidance instructs people not to use ophthalmic products labeled as homeopathic. Listings still turn up because enforcement takes time to reach every seller, not because a given product was cleared.
What happened to TRP’s eye drop products?
We reformulated our condition-specific eye care line from drops into Fast Dissolving Tablets. The active approach stayed the same; the delivery format changed to one that does not carry the sterility risk of an eye-applied product.
Is Gentle Eyes Lubricant Eye Drops a homeopathic product?
No. It is a non-medicated lubricant eye drop for dryness and comfort. It is not homeopathic and does not make the condition-specific symptom claims our earlier drop products did.
What should I use now that this category is gone?
That depends on the symptom. For everyday irritation, allergy-related itching, floaters, or aging-eye discomfort, our Fast Dissolving Tablets cover those needs orally. For simple dryness, a lubricant drop works. For anything sudden, painful, or vision-affecting, see a doctor first.
References
[1] FDA Center for Drug Evaluation and Research / Center for Biologics Evaluation and Research. “Homeopathic Drug Products – Guidance for FDA Staff and Industry.” FDA, December 2022. https://www.fda.gov/media/163755/download
[2] FDA Center for Drug Evaluation and Research. “Homeopathic Products.” FDA, last modified January 17, 2025. https://www.fda.gov/drugs/understanding-over-counter-medicines/homeopathic-products
[3] UC Davis Health News. “Eye drop recall 2026: FDA flags over 3 million bottles; Eye doctors explain what you should know.” UC Davis Health, April 6, 2026. https://health.ucdavis.edu/news/headlines/eye-drop-recall-2026-fda-flags-over-3-million-bottles-eye-doctors-explain-what-you-should-know/2026/04
[4] “Homoeopathic eye drops in the treatment of mild-to-moderate dry eye disease: Randomised, prospective, multicentre, single-masked study.” PubMed / NCBI, 2024. https://pubmed.ncbi.nlm.nih.gov/38062637/
[5] “Stop using homeopathic eye drops.” Popular Science. https://www.popsci.com/health/fda-homeopathic-eye-drops/
[6] FDA Center for Drug Evaluation and Research. “What You Should Know about Eye Drops.” FDA, last modified June 15, 2026. https://www.fda.gov/drugs/buying-using-medicine-safely/what-you-should-know-about-eye-drops
